The Number of Retained Rectosigmoid Markers During Colonic Transit Testing Does Not Reliably Predict the Presence of Dyssynergic Defecation

2011 ◽  
Vol 140 (5) ◽  
pp. S-609
Author(s):  
Monthira Maneerattanaporn ◽  
Jason Baker ◽  
William D. Chey
2012 ◽  
Vol 107 ◽  
pp. S711
Author(s):  
Andrea Shin ◽  
Michael Camilleri ◽  
Ashley Nadeau ◽  
Sara Nullens ◽  
Jong Chul Rhee ◽  
...  

2006 ◽  
Vol 36 (21) ◽  
pp. 43
Author(s):  
AMY ROTHMAN SCHONFELD

2020 ◽  
Author(s):  
Kongliang Sun ◽  
Qun Qian ◽  
Jinxiang Hu ◽  
Weicheng Liu ◽  
Yuntian Hong ◽  
...  

2021 ◽  
Vol 10 (9) ◽  
pp. 2027
Author(s):  
Samuel Tanner ◽  
Ahson Chaudhry ◽  
Navneet Goraya ◽  
Rohan Badlani ◽  
Asad Jehangir ◽  
...  

Patients with chronic constipation who do not respond to initial treatments often need further evaluation for dyssynergic defecation (DD) and slow transit constipation (STC). The aims of this study are to characterize the prevalence of DD and STC in patients referred to a motility center with chronic constipation and correlate diagnoses of DD and STC to patient demographics, medical history, and symptoms. High-resolution ARM (HR-ARM), balloon expulsion testing (BET) and whole gut transit scintigraphy (WGTS) of consecutive patients with chronic constipation were reviewed. Patients completed questionnaires describing their medical history and symptoms at the time of testing. A total of 230 patients completed HR-ARM, BET, and WGTS. Fifty (22%) patients had DD, and 127 (55%) patients had STC. Thirty patients (13%) had both DD and STC. There were no symptoms that were suggestive of STC vs. DD; however, patients with STC and DD reported more severe constipation than patients with normal transit and anorectal function. Patients with chronic constipation often need evaluation for both DD and STC to better understand their pathophysiology of symptoms and help direct treatment.


2019 ◽  
Vol 37 (6) ◽  
pp. 478-485 ◽  
Author(s):  
Claire Zar-Kessler ◽  
Braden Kuo ◽  
Elizabeth Cole ◽  
Anna Benedix ◽  
Jaime Belkind-Gerson

Objectives: Chronic constipation is a common childhood problem and often caused or worsened by abnormal dynamics of defecation. The aim of this study was to assess the benefit of pelvic floor physical therapy (PFPT), a novel treatment in pediatrics for the treatment of chronic constipation with dyssynergic defecation. Methods: This was a retrospective study of 69 children seen at a pediatric neurogastroenterology program of a large tertiary referral center for chronic constipation and dyssynergic defecation, determined by anorectal manometry and balloon expulsion testing. We compared the clinical outcome of patients who underwent PFPT (n = 49) to control patients (n = 20) whom received only medical treatment (laxatives/stool softeners). Additionally, characteristics of the treatment group were analyzed in relation to therapeutic response. Results: Thirty-seven (76%) of the patients who received physical therapy had improvement in constipation symptoms, compared to 5 (25%) of the patients on conservative treatment (p < 0.01). Additionally, patients who received pelvic physical therapy had fewer hospitalizations for cleanouts (4 vs. 25%, p = 0.01) and ­colonic surgery than those that were treated with medical therapy exclusively (0 vs. 10%, p = 0.03). Among the patients who received physical therapy, those that suffered from anxiety and/or low muscle tone had a higher response rate (100%). There were no adverse effects from the intervention. Conclusion: The new field of pediatric PFPT is a safe and effective intervention for children with dyssynergic defecation causing or contributing to chronic constipation, particularly in children whose comorbidities include anxiety and low ­muscle tone.


Sign in / Sign up

Export Citation Format

Share Document